enVVeno Medical Corporation
NVNO
$10.53
$0.232.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.69% | 32.19% | -48.66% | 27.71% | -10.40% |
| Total Depreciation and Amortization | -2.50% | -7.69% | 6.56% | 0.00% | -5.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.51% | -52.27% | 80.24% | -25.62% | 13.94% |
| Change in Net Operating Assets | 22.86% | -152.79% | 375.10% | -259.70% | -155.83% |
| Cash from Operations | 21.61% | -18.22% | 7.54% | 21.29% | -19.39% |
| Capital Expenditure | -- | 100.00% | -- | -- | 55.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.54% | 29.15% | -45.65% | 147.06% | -277.43% |
| Cash from Investing | 14.54% | 29.38% | -45.74% | 147.04% | -277.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 224.48% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 224.48% | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 404.20% | 44.01% | -175.49% | 107.32% | -204.03% |